Jove
Visualize
お問い合わせ
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 腫瘍学とがん発生
  9. 分子標的
  11. マクロベシクル分裂増幅によるカスケードによる傍観者細胞毒性を誘導するポリアミノ酸の腫瘍選択的自己組み立てネットワーク
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 腫瘍学とがん発生
  9. 分子標的
  11. マクロベシクル分裂増幅によるカスケードによる傍観者細胞毒性を誘導するポリアミノ酸の腫瘍選択的自己組み立てネットワーク

関連する実験動画

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

3.0K

マクロベシクル分裂増幅によるカスケードによる傍観者細胞毒性を誘導するポリアミノ酸の腫瘍選択的自己組み立てネットワーク

Jinfeng Sun1, Yang Ma1,2, Jingshan Sun1

  • 1State Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 5625 Renmin Street, Changchun 130022, P. R. China.

Journal of the American Chemical Society
|January 6, 2026

PubMed で要約を見る

まとめ
この要約は機械生成です。

新しいポリ (D-アミノ酸) コポリマーが腫瘍で自己組み立てられ,細胞毒性信号を増幅する局所的マイクロベシクルを形成する. このアプローチは腫瘍の成長を効果的に抑制し,持続的な傍観者効果によって転移を抑制します.

科学分野:

  • バイオマテリアル科学
  • ナノテクノロジー
  • 腫瘍学

背景:

  • 細胞外膀 (EV) は細胞間通信と治療の提供に不可欠です.
  • 現在のEV戦略は 腫瘍の蓄積と活動が弱くなるような 限界に直面しています
  • 治療効果を高めるには,腫瘍内での局所的EV生成が必要である.

研究 の 目的:

  • 腫瘍内における酵素誘発の自己組み立てと局所的な治療用EV生成のための新しいポリマーを開発する.
  • セルフアセンブリメカニズムとその結果となるマイクロベシクル (MV) 形成と増幅カスケードを調査する.
  • 開発されたシステムの細胞毒性効果と腫瘍抑制能力を評価する.

主な方法:

  • アルカリリンフォスファテーゼ (ALP) に反応するポリアミノ酸コポリマー (EG45-D-K-D-pYA) の設計と合成.
  • ALP触媒によるゼータポテンシャルとβシート含有量の変化を含む,ポリマーの自己組み立ての特徴.
  • in situ MV生成,細胞毒性,および腫瘍成長抑制の評価 in vivo

主要な成果:

  • EG45-D-K-D-pYAはALP触媒による自己アセンブリを腫瘍局所化された正電荷ネットワークに受け,MV形成と分裂カスケードを誘発する.

さらに関連する動画

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

関連する実験動画

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

3.0K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

関連する概念動画

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Metastasis02:30

Metastasis

6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

8.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  • ポリマーの水解と組成は,納米粒子からネットワークへの移行を促し,電荷と二次構造に重大な変化をもたらした.
  • このシステムは,強力な腫瘍選択性サイト毒性 (IC50 = 0. 58 μM),in situMV生成 (ζ = +32. 9 mV),および4つのMV生成を通じて持続したサイト毒性を示した.
  • 腫瘍の成長が90. 1%抑制され,転移が著しく抑制された.

    • 結論:

    • 開発されたポリ (D-アミノ酸) コポリマーは,腫瘍内の治療用マイクロベシクルの酵素誘発による局所的生成を可能にします.
    • この戦略は,自己持続的な分裂カスケードを通じて細胞毒性信号を放大し,強固な傍観者細胞毒性を誘発する.
    • このアプローチは,持続的な腫瘍抑制と転移抑制のための有望な腫瘍選択的治療戦略を提供します.